ClinicalTrials.gg
Enrolling by invitationNCT07490548Updated Apr 1, 2026

Lifestyle Medicine Adherence, Mental Wellbeing, and Quality of Life in Pediatric Oncology in Ecuador

An observational study in Childhood Cancer Survivors, sponsored by Universidad de Especialidades Espiritu Santo. Enrolling by invitation at 4 sites in Ecuador. Open to participants aged 3 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-04-01.

Sponsored by Universidad de Especialidades Espiritu Santo · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
62
Ages
3 Years to 17 Years
Sex
All
01

Study summary

Background: Advances in pediatric oncology have significantly improved survival rates; however, many children and adolescents with cancer experience persistent physical and psychological challenges that negatively affect their health-related quality of life (HRQoL). Lifestyle medicine (comprising regular physical activity, restorative sleep, optimal nutrition, stress management, avoidance of risky substances, and positive social connections) is increasingly recognized as a determinant of well-being in chronic disease populations. However, evidence on its role in pediatric oncology survivorship remains limited, particularly in low- and middle-income countries like Ecuador.

Methods: A multicenter cohort study with a 6-month follow-up will evaluate the association between adherence to lifestyle medicine pillars and HRQoL among children and adolescents who have completed active cancer treatment in Ecuador. A total of 57-62 participants aged 3 to \<18 years receiving care in major pediatric oncology centers will be recruited. The adherence to the 6 pillars of lifestyle medicine will be assessed using validated questionnaires. HRQoL will be measured using the Pediatric Quality of Life Inventory (PedsQL), while mental health outcomes will be evaluated through validated PROMIS measures. Sociodemographic and clinical variables will also be collected. Cross-sectional and longitudinal generalized linear mixed models will be used to explore associations between lifestyle behaviors, mental health, and HRQoL, adjusting for relevant confounders.

Conclusion: This study will provide one of the first comprehensive assessments of the prevalence, time trends, and associated factors of lifestyle medicine adherence and its relationship with quality of life and mental health among pediatric oncology patients in Ecuador. Results may help identify modifiable lifestyle factors associated with better wellbeing and inform future supportive care strategies and lifestyle-based interventions for children and adolescents with cancer.

02

Conditions studied

  • Childhood Cancer Survivors

Keywords

  • lifestyle medicine
  • quality of life
  • mental health
  • health-related quality of life
03

In context

Psychological Well-Being

2,193 studies on the registry are indexed under Psychological Well-Being; 728 are open to participants now.

This study's planned enrollment of 62 is below the median of 300 across 358 observational studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

Universidad de Especialidades Espiritu Santo is the lead sponsor of 10 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children and adolescent aged 3 and ˂18 years diagnosed with cancer by imaging, cytology, or pathology who have currently finished active cancer treatment (chemotherapy, radiotherapy, surgery).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children and adolescent aged 3 and ˂18 years.
  • Participants diagnosed with cancer by imaging, cytology, or pathology who have currently finished active cancer treatment (chemotherapy, radiotherapy, surgery).
  • Individuals attending medical consultations follow-up at one of the oncology centers from the study.

Exclusion criteria

Exclusion Criteria:

  • Individuals who suffer critical conditions (i.e., disease relapse, severe neutropenia, treatment toxicities, psychological disturbances, etc.) at the time of the recruitment.
  • Participants who are not authorized by the parents or legal guardians to participate in the research project.
  • Participants who do not agree to take part in the research project.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
62 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Children and adolescent aged 3 and ˂18 years who have currently finished active cancer treatment

    A multicenter cohort study with a 6-month follow-up will be performed to obtain information about the adherence to the six lifestyle medicine pillars (restorative sleep, stress management, adequate nutrition, optimal physical activity, avoidance of harmful substances, and healthy social relationship), HRQoL, and mental wellbeing (anxiety and depression symptoms) among children and adolescents who finished active cancer treatment in Ecuador. Data will be collected through phone call / video call interviews or by online surveys, depending on each parent/caregiver preference. Interviewers will read questions verbatim) to reduce bias. Follow-up will be established 6 months from the first evaluation.

06

What researchers measure

Primary outcomes

  1. Health-Related Quality of Life (HRQoL)

    Assessed using the Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales and PedsQL 3.0 Cancer Module. A higher score indicates better HRQoL. Unit of Measure: Score on a scale from 0 to 100.

    Time frame: Baseline and 6 months

  2. Mental Wellbeing - Depressive Symptoms

    Assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Early Childhood Parent-Report Short Form v1.0, PROMIS Parent Proxy Bank v2.0, or PROMIS Pediatric Short Form GenPop v3.0, depending on participant age. A higher T-score indicates more severe symptoms. Unit of Measure: T-score (standardized score with a mean of 50 and standard deviation of 10)

    Time frame: Baseline and 6 months

  3. Mental Wellbeing - Anxiety Symptoms

    Assessed using the PROMIS Early Childhood Parent-Report Short Form v1.0, PROMIS Parent Proxy Short Form v2.0, or PROMIS Pediatric Short Form GenPop v3.0, depending on participant age. A higher T-score indicates more severe symptoms. Unit of Measure: T-score (standardized score with a mean of 50 and standard deviation of 10).

    Time frame: Baseline and 6 months

  4. Lifestyle Medicine Adherence - Overall

    For each of the six lifestyle medicine pillars (optimal nutrition, regular physical activity, restorative sleep, stress management, avoidance of harmful substances, and positive social connections), participants will be classified as meeting or not meeting the corresponding clinical or oncological guideline-based recommendations using data from the validated instruments described in the protocol. An overall binary classification (meets overall recommendations / does not meet overall recommendations) will be derived based on predefined criteria (e.g., meeting a minimum number of pillars or meeting all pillars) in accordance with supportive care guidelines for pediatric oncology survivorship. Unit of Measure: Binary classification (meets overall lifestyle medicine recommendations / does not meet overall recommendations).

    Time frame: Baseline and 6 months

Secondary outcomes

  1. Adherence to Optimal Nutrition

    Assessed using the KIDMED (Mediterranean Diet Quality Index) questionnaire. A higher score indicates better adherence to a Mediterranean diet.

    Time frame: Baseline and 6 months

  2. Diet Quality

    Assessed using the Diet Quality Questionnaire (DQQ) to calculate the Global Dietary Recommendations (GDR) score. A higher score indicates greater adherence to healthy dietary practices. Unit of Measure: Score on a scale from 0 to 18.

    Time frame: Baseline and 6 months

  3. Body Mass Index (BMI)

    Calculated from weight and height extracted from the medical record. Weight and height will be combined to report BMI in kg/m\^2. Unit of Measure: kg/m\^2

    Time frame: Baseline and 6 months.

  4. Adherence to Physical Activity Guidelines

    Assessed using the Youth Activity Profile (YAP), the Global School-Based Student Health Survey (GSHS) Physical Activity Module, and the Questionnaire for the Measurement of Physical Activity and Sedentary Behavior in Children (C-MAFYCS) depending on the age of the participant. Meeting the World Health Organization (WHO) guidelines is defined as an average of at least 60 minutes per day of moderate-to-vigorous physical activity. Unit of Measure: Binary classification (meets guidelines / does not meet guidelines).

    Time frame: Baseline and 6 months.

  5. Adherence to Sleep Guidelines

    Sleep duration is calculated from self- or parent-reported bedtimes and wake-up times. Meeting the National Sleep Foundation guidelines is defined as the following age-appropriate sleep duration ranges: 8-10 hours for adolescents, 9-11 hours for school-age children, 10-13 hours for preschoolers, and 11-14 hours for toddlers. Unit of Measure: Binary classification (meets guidelines / does not meet guidelines).

    Time frame: Baseline and 6 months.

  6. Social Connections

    Assessed using the Strengths and Difficulties Questionnaire (SDQ), the Multidimensional Scale of Perceived Social Support (MSPSS) for family and friends support, and the Health Behavior in School-aged Children (HBSC) social support subscales for classmates and teachers support. These measures assess peer relationship problems, prosocial behavior, and perceived support from family, friends, teachers, and classmates. Unit of Measure: Score (varies by instrument).

    Time frame: Baseline and 6 months.

  7. Stress Management

    Assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Psychological Stress Experiences (Pediatric Short Form v1.0 or Parent Proxy Short Form v1.0). A higher T-score indicates a more severe psychological stress experience. Unit of Measure: T-score (standardized score with a mean of 50 and standard deviation of 10).

    Time frame: Baseline and 6 months.

  8. Avoidance of Harmful Substances

    Assessed through questions about secondhand smoke exposure, personal substance use (cigarettes, alcohol, cannabis, e-cigarettes), and energy drink consumption. For participants aged 11 and older, this includes the lifetime prevalence and frequency of use. Unit of Measure: Binary (yes/no) for exposure and use; frequency counts for personal use.

    Time frame: Baseline and 6 months.

07

Study locations

4 sites
  • SOLCA Cuenca
    Cuenca, Ecuador
  • SOLCA Guayaquil
    Guayaquil, Ecuador
  • Hospital Baca Ortiz
    Quito, Ecuador
  • Hospital SOLCA Quito
    Quito, Ecuador
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07490548
Lead sponsor
Universidad de Especialidades Espiritu Santo
Responsible party
José Francisco López Gil (Senior Reasearcher, Universidad de Especialidades Espiritu Santo) — Principal investigator
First posted
Mar 24, 2026
Start date
May 1, 2025
Primary completion
Apr 30, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Apr 1, 2026

Study contacts

José Francisco López-Gil, PhD
principal investigator · Universidad de Especialidades Espiritu Santo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion